Analysis of the Mechanism Underlying the Vasodilator Action of Carvedilol in Pithed Spontaneously Hypertensive Rats
- 1 January 1988
- journal article
- Published by Springer Nature in Drugs
- Vol. 36 (6) , 31-36
- https://doi.org/10.2165/00003495-198800366-00007
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.Hypertension, 1988
- Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of α1-adrenoceptor blockadeEuropean Journal of Pharmacology, 1987
- Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive PropertiesJournal of Cardiovascular Pharmacology, 1987
- Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.1987
- Clinical pharmacology of carvedilol in normal volunteersClinical Pharmacology & Therapeutics, 1987
- The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.1987
- Efficacy of carvedilol (BM14, 190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemiaThe American Journal of Cardiology, 1985
- Haemodynamic Effects of Carvedilol, A New Beta-Adrenoceptor Blocker and Precapillary Vasodilator in Essential HypertensionJournal Of Hypertension, 1984
- DIRECT VASODILATATION BY LABETALOL IN ANAESTHETIZED DOGSBritish Journal of Pharmacology, 1980
- Antihypertensive activity of 1-[2-(1,3-dimethyl-2-butenylidene)-hydrazino]-phthalazine (DJ-1461), a new phthalazine derivativeEuropean Journal of Pharmacology, 1974